REST-DRD2 mechanism impacts glioblastoma stem cell–mediated tumorigenesis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
REST-DRD2 mechanism impacts glioblastoma stem cell–mediated tumorigenesis
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-02-27
DOI
10.1093/neuonc/noz030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- REST, a master transcriptional regulator in neurodegenerative disease
- (2018) Jee-Yeon Hwang et al. CURRENT OPINION IN NEUROBIOLOGY
- Vaccine-based immunotherapeutic approaches to gliomas and beyond
- (2017) Michael Weller et al. Nature Reviews Neurology
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway
- (2016) Hongli Huang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Glioma and microglia, a double entendre
- (2016) Korneel Grauwet et al. NATURE IMMUNOLOGY
- Progress in glioma diagnosis, classification and treatment
- (2016) Patrick Y. Wen et al. Nature Reviews Neurology
- An expression based REST signature predicts patient survival and therapeutic response for glioblastoma multiforme
- (2016) Jianfeng Liang et al. Scientific Reports
- The REST remodeling complex protects genomic integrity during embryonic neurogenesis
- (2016) Tamilla Nechiporuk et al. eLife
- TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activation
- (2015) M T Epping et al. CELL DEATH AND DIFFERENTIATION
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells
- (2015) Ulf D. Kahlert et al. INTERNATIONAL JOURNAL OF CANCER
- Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact
- (2015) P. Sathyan et al. JOURNAL OF NEUROSCIENCE
- Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma
- (2015) Jie Li et al. Oncotarget
- Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells
- (2014) Yun Bai et al. GLIA
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease
- (2012) Matthew P Wagoner et al. BMC GENOMICS
- Epigenetics and epilepsy
- (2012) Avtar Roopra et al. EPILEPSIA
- Effects on promoter activity of common SNPs in 5′ region of GABRB3 exon 1A
- (2012) Miyabi Tanaka et al. EPILEPSIA
- REST Is a Novel Prognostic Factor and Therapeutic Target for Medulloblastoma
- (2012) P. Taylor et al. MOLECULAR CANCER THERAPEUTICS
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
- (2012) Luciano Conti et al. PLoS One
- Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death
- (2012) K.-M. Noh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- REST Regulates Oncogenic Properties of Glioblastoma Stem Cells
- (2012) Mohamed M. Kamal et al. STEM CELLS
- Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCFβ-TRCP in neuroblastoma cells
- (2011) Akanksha Singh et al. CANCER
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Brain tumor stem cells: The cancer stem cell hypothesis writ large
- (2010) Peter B. Dirks Molecular Oncology
- NFKBIADeletion in Glioblastomas
- (2010) Markus Bredel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myoblast-Derived Neuronal Cells Form Glutamatergic Neurons in the Mouse Cerebellum
- (2010) Vidya Gopalakrishnan et al. STEM CELLS
- The Pathobiology of Glioma Tumors
- (2009) Candece L. Gladson et al. Annual Review of Pathology-Mechanisms of Disease
- The Rest Repression of the Neurosecretory Phenotype Is Negatively Modulated by BHC80, a Protein of the BRAF/HDAC Complex
- (2009) A. Klajn et al. JOURNAL OF NEUROSCIENCE
- SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer
- (2008) A. C. Moss et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started